Maze Therapeutics, Inc. · NASDAQ:MAZE

James Tananbaum's stake in Maze Therapeutics, Inc. fell to 1.40% (Schedule 13G/A)

Event Sep 30, 2025 · Filed Nov 14, 2025

James Tananbaum's stake in Maze Therapeutics, Inc. fell to 1.40%, 608,948 shares, as a passive investor on Sep 30, 2025. Filed Nov 14, 2025 (Schedule 13G/A).

Stake
1.40%
Shares
608,948
Intent
Passive
What changed
Fell below 5%
Filed together
5 holders

The filing in full

HolderStakeShares
Foresite Capital Fund IV, L.P.1.20%522,657
Foresite Capital Management IV, LLC1.20%522,657
Foresite Capital Fund V, L.P.0.20%86,291
Foresite Capital Management V, LLC0.20%86,291
James Tananbaum1.40%608,948

Source

View original at SEC

Related